Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
UNIVERSITÄT LEIPZIG (@UniLeipzig) / Twitter
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells
Mitarbeiter des Rudolf-Boehm-Institutes
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
application note Metafectene K2 Adipocyten-pDNA - final
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
UNIVERSITÄT LEIPZIG (@UniLeipzig) / Twitter
Pharmaceutics & Novel Drug Delivery Systems
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Rudolf-Boehm-Institut für Pharmakologie und Toxikologie
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy
